J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 173 http://jad.tums.ac.ir Published Online: June 30, 2020 Original Article Seroprevalence Study on West Nile Virus (WNV) Infection, a Hidden Viral Disease in Fars Province, Southern Iran Masoumeh Amin 1,2 ; Morteza Zaim 1 ; *Hamideh Edalat 1 ; *Hamid Reza Basseri 1 ; Mohammad Reza Yaghoobi-Ershadi 1 ; Farhad Rezaei 3 ; Kourosh Azizi 2 ; Mostafa Salehi- Vaziri 4 ; Mohsen Ghane 5 ; Saideh Yousefi 1 ; Sorna Dabaghmanesh 2 ; Sedigheh Kheirandish 6 ; Mohammad Esmaeil Najafi 7 ; Jalal Mohammadi 2 1 Department of Medical Entomology and Vector Control, School of Health, Tehran University of Medical Sciences, Tehran, Iran 2 Department of Medical Entomology and Vector Control, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran 3 Department of Medical Virology, School of Health, Tehran University of Medical Sciences, Tehran, Iran 4 Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran 5 Department of Clinical Sciences, School of Veterinary Science, Shiraz University, Shiraz, Iran 6 Department of Oral and Maxillofacial Pathology, Bushehr University of Medical Sciences, Bushehr, Iran 7 Environmental Health Unit, Faculty of Health, Shiraz University of Medical Sciences, Shiraz, Iran (Received 12 Sep 2019; accepted 10 Dec 2019) Abstract Background: West Nile Virus, a mosquito-borne flavivirus, causes a variety of symptoms in human, from asymp- tomatic infection to neuroinvasive disease. Several studies have been conducted on the seroprevalence of WNV in- fection in different areas from Iran. This study was performed to find the presence of antiviral antibodies in human serum among some high risk population and awareness of health care staff about symptom of the WNV infection. Methods: Study performed in five geographical districts based on high population of immigrant and domestic birds and prevalence of the antiviral antibodies in horses which was reported previously. Totally 150 human blood sam- ples were collected during 2018. The samples collected from patients referred to the clinics. The ELISA method used to detect IgG and IgM antibody against WNV. Logistic regression models used to analyze the effect of sex, age, keeping birds and urban/rural residence on the risk of infection. The awareness of health care staff about symp- tom of infection surveyed. Results: From all blood donors, 41 samples (27.33%) showed positive to IgG antibody. From which 56.10% were males and remaining females. None of the mentioned factors had a significant relationship. Health care staff had less attention to the infection. Conclusions: Although the prevalence of antibodies was relatively high, due to the similarity to other viral diseases, health care staff had less attention to the disease. The study showed that people in these areas have been exposed to the virus. Further research activities are recommended for control of this arbovirus. Keywords: West nile virus; Seroprevalence; Iran Introduction West Nile Virus is a mosquito-borne vi- rus that infects various mammal species es- pecially horses and humans; however, the most commonly West Nile Virus infected animals are birds that serve as the reservoir host (1, 2). The birds show different signs of WNV infection as some of them become ill with high symptom of the disease and also die, while some others show no symptom. It is stated that house sparrows and crows are so susceptible to WNV infection but they are poor reservoir for transmission of virus via *Corresponding authors: Dr Hamideh Edalat, E-mail: edalat@tums.ac.ir, Dr Hamid Reza Basseri, E-mail: basserih@tums.ac.ir http://shirazu.ac.ir/en/node/1510#Veterinary mailto:edalat@tums.ac.ir mailto:basserih@tums.ac.ir J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 174 http://jad.tums.ac.ir Published Online: June 30, 2020 seems to be more responsible for conserva- tion and transmission of the virus in United States (5). Furthermore, human and equines are incidental as well as dead-end hosts (6, 7). The virus was first found from the blood of a woman in Northern Uganda in a region close to the Nile River in 1937. WNV is wide- spread in Africa, Europe, Asia, America and Caribbean Islands. In nature, birds are the res- ervoir of virus and mosquitoes get the virus from birds (8-10). The mosquitoes of the Culex species play an important role in the WNV transmission cycle (11-13). Humans become infected via mosquito bites. It can also get the virus through organ transplantation, breast feeding and blood transfusion. Human infec- tions are mild or asymptomatic. Severe dis- ease is stated in older patients. Most human infections have no signs (80%); nearly 20% of those infected develop a mild infection known as West Nile fever. Symptoms of the disease include vomiting, diarrhea, headache, backache, muscle aches, skin rash and en- larged lymph nodes. In severe cases, nervous system problems like inflammation of brain and spinal cord with hemorrhage, perivascu- lar cuffing and neuronal degeneration have been detected. WNV has been measured a mild pathogen causing self-limiting outbreaks, but some newer isolates of virus seem to be lethal; therefore an increased incidence of neu- rological disease and a higher case fatality rate have been associated (4, 15, 16). Several studies have been carried out on the presence of antiviral antibodies in human serum in the world (17, 18, 19). These antiviral antibodies are Immunoglobulin M (IgM) and Immuno- globulin G (IgG). IgM is the first antibody to be immediately developed when any foreign particle is introduced. WNV-specific IgM an- tibodies are usually detectable 3 to 8 days after onset of illness and persist for 30 to 90 days, but longer persistence has been docu- mented. Therefore, positive IgM antibodies occasionally may reflect a past infection. If serum is collected within 8 days of illness onset, the absence of detectable virus-spe- cific IgM does not rule out the diagnosis of WNV infection, and the test may need to be repeated on a later sample. IgG is a long term response for any disease and thus protect our body from viral and bacterial attacks. WNV IgG antibodies generally are detected shortly after IgM antibodies and persist for many years following a symptomatic or asymptomatic in- fection. Therefore, the presence of IgG anti- bodies alone is only evidence of previous in- fection and clinically compatible cases with the presence of IgG, but not IgM, should be evaluated for other etiologic agents. The ef- fect of IgM is temporary and they disappear after 2–3 weeks of their production. IgG is produced at the later stage of infection, but their effect is for a long time and helps in complete eradication of infections or diseas- es. Given that we only found IgG antibodies in the blood samples of people living in this study area, this indicates their contact with the virus in the past and possibly their WNV infection. IgM provides immediate response while IgG responds later with the permanent eradication of antigen and its effect is lasting. The amount of IgM produced at the time of exposure to antigen is six times greater than IgG (20-24). A study from 2008 to 2009 showed widespread circulation of WNV in Iran, mainly in southwestern provinces where the virus probably circulates every year (25). Previous seroepidemiological studies in Iran revealed the presence of WNV antibody in different regions of Iran (26-29). Apart from the study in Chabahar, South of Iran, no fur- ther study has been conducted in south of Iran (30). Although a study on the serum of horses in Fars Province has reported a high incidence of antibody against the virus (25), no coherent study has been carried out on the human infection in Fars Province, South- ern Iran. Therefore, the aim of this study was to determine the presence of antiviral an- tibodies and previous exposure in human serum as well as of awareness of health staff J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 175 http://jad.tums.ac.ir Published Online: June 30, 2020 and clinicians about symptom of the WNV. The results of current study demonstrate the primary information about situation of WNV in the intended area. Materials and Methods Geographical area and Date of Research This study was carried out in five se- lected geographic counties of Fars Province, Southern Iran during 2018 (Fig. 1). Fars Prov- ince is located in the South of Iran between 29°37′ N and 52°32′ E and covers an area of 122,400km 2 . The study areas include Shiraz, Zarqan, Marvdasht and Sepidan Counties as well Maharloo Wetland area. Generally, Shi- raz district has urban texture and the habit- ants do not keep domestic animals at home. Therefore, the habitants are more common host for mosquito bites. In contrary, Marvdasht, Zarqan, Sepidan and Maharloo Counties have rural texture with many livestock and thus the mosquito vectors have more access to animal blood source rather than human. In addition, the criteria for chosen areas were presence of high population of immigrant and domestic birds as suspected reservoirs of WNV and high prevalence of antiviral antibodies in horses (according to previous study). Furthermore, the occurrence of suspected mosquito vec- tors in the area was considered (according to primary pilot in the current study). Awareness of Sign and Symptom about WNV A cross sectional study was conducted which assessed awareness of sign and symp- tom of WNV disease among health care staff and practitioners of selected health facilities by using an open-ended questionnaire. The data were collected from 12 health centers. According to data obtained from a stu- dent thesis at Shiraz Veterinary School (31), antibody titers were higher in horses in Shi- raz, Zarqan, Marvdasht and Sepidan district than other areas of Fars Province. The Ma- harloo Wetland area, which hosts the largest number of migratory birds in the province, was also selected as one of the study areas. Three centers from Marvdasht, three centers from Sepidan, one center from Maharloo, two centers from Zarqan and three centers from Shiraz were selected. At these centers, all staff were asked about their knowledge of the symp- toms of WNV infection. Serum Sample Collection The serum samples were collected from patients who referred to the clinics of five selected areas during 2018. The sample size was 150 individuals. The desired parameters of each participant including age, gender, keeping birds and urban/rural residency were considered in a questionnaire. Five milliliter of venous blood was taken and the sera were stored at -20 °C until tested. All serum sam- ples were referred to the Viral Laboratory, Department of Medical Virology, School of Public Health, Tehran University of Medical Sciences and were examined for antibody detection (IgG and IgM) against WNV. Enzyme Linked Immuno Sorbent Assay (ELISA) This test was carried out by Euroimmune kit (EI_2662-9601G/M) manufactured in Ger- many to detect anti WNV antibodies (Immu- noglobulin G and Immunoglobulin M) in the serum sample. The test was performed fol- lowing the kit manufacturer’s protocol. The chosen kit was so specific without any cross activity to other Flaviviruses. The antigen source was a recombinant, detergent-extract- ed glycoprotein E of WNV from the mem- brane fraction of human cells (32). IgM capture Immunoassays: Testing was performed according to the manufacturers’ in- structions. Serum samples, along with the con- trols and cutoff calibrator, were diluted 1:100 in sample diluent and then added to microwells coated with anti-human IgM antibodies. Fol- J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 176 http://jad.tums.ac.ir Published Online: June 30, 2020 lowing a 1h incubation, the wells were washed and reconstituted recombinant WNV antigen was added. An incubation of 2h occurred, fol- lowed by a second wash and the addition of horseradish peroxidase (HRP)-conjugated mouse anti-flavivirus conjugate. After 30 min, a third wash step was employed, and a substrate consisting of tetramethylbenzidine (TMB) and hydrogen peroxide was added to each well. After 10min, 1Molar sulfuric acid was added to each well to stop the reaction, and the absorbance of each well was deter- mined spectrophotometrically at 450nm (32). WNV IgG Enzyme Immunoassays: Sam- ples were diluted 1:100 in sample diluent and added to micro wells coated with recombi- nant WNV antigen and incubated for 60min. After the wells were washed, HRP-conju- gated Fc fragment-specific anti-human IgG was added and the wells were incubated for 30min. A second wash was performed, and TMB substrate was incubated in the wells for 10min. To stop the reaction, 1Molar sul- furic acid was added to each well, and the absorbance of each well was determined spec- trophotometrically at 450nm (32). Statistical analysis Logistic regression method (SPSS statis- tical package version 19.0; IBM SPSS Insti- tute, USA) was used to evaluate significant differences in the seroprevalence positive rates by different demographic factors and a sig- nificance level of 0.05 was considered sta- tistically. Ethical statement The study suggestion was accepted by the Research Ethics Committee of the Teh- ran University of Medical Sciences, Tehran, Iran (No.IR.TUMS.SPH.REC.1396.4204) and informed written consent was obtained from the subjects for blood sampling. Results The demographic characteristics of par ticipants are presented in Table 1. Overall, 150 volunteers participated in the study included 63 (42.00%) from urban and 87 (58.00%) from rural area. The majority of participants was from Shiraz County (40.00%) and the minimum of them was from Sepidan (13.33 %) followed by Zarqan (14.67%), Maharloo (16.00%) and Marvdasht district (16.00%). About one third of the participants (32.67%) stated that they have birds at home. The ma- jority of participants belonged to the middle age group (30–50 years). Overall the preva- lence of positive IgG antibody was detected among 27.33% participants (41 out of 150), which included 23 males (56.10%) and 18 females (43.90%). Among them, 27 (18.00 %) cases were from Shiraz County, 3 (2.00 %) were from Zarqan County, 4 (2.67%) cases were from Maharloo wetland area, 2 (1.33%) cases were from Sepidan County and 5 (3.33 %) cases were from Marvdasht County (Ta- ble 2). The prevalence of antibodies against WNV was not statistically significant by gen- der (P= 0.493). The positive cases based on the age group in study area are shown in Table 3. The infec- tion rate to WNV among different age groups was so varied in different counties. None of the positive cases was found among 20–30 years old group in all counties, while the ma- jority of positive case from Shiraz County occurred at age group of 31–40 followed by 41–50 year olds. Considering the age groups, the prevalence of antibody against WNV was not significantly different (P= 0.832). The pos- itive cases based on keeping birds (as potent reservoirs) at home in five counties are shown in Table 4. The positive WNV IgG antibody was categorized based on keep birds as sus- pected reservoirs. The residents who live in rural district had more infection to WNV vi- rus comparatively. About one third of par- ticipants (32.66%) stated that they keep birds J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 177 http://jad.tums.ac.ir Published Online: June 30, 2020 at home and among them 14 (28.56%) was positive to WNV IgG antibody. The partici- pants from Maharloo who kept birds at home comparatively had more positive cases (12.24 %) and the minimum positive cases was oc- cur among inhabitants of Shiraz County (2.04%). However, the prevalence of posi- tive antibodies against WNV was not signif- icantly different among participants who kept birds (P= 0.632).The positive cases accord- ing to living in urban/rural areas have been shown in Table 5. Among all participant 42 % live in urban and 58% in rural areas where- as the positive cases were comparatively higher in the urban areas. Between all pos- itive cases, 32.92% were urban and 21.84% in rural areas. The majority of positive cases were found in urban area of Shiraz County. The prevalence of positive cases was not statistically significantly different between ru- ral and urban cases (P= 0.291), but it was significantly different between rural and ur- ban cases of Shiraz County. Although the prevalence of WNV infection was relatively high, due to the similarity of symptoms to other viral diseases, health care staff had less attention to the disease. Table 1. Demographic characteristics of participants from five districts, Fars Province, Southern Iran, 2018 District No. Percent from total (%) Gender Male Percent from total (%) Female Percent from total (%) Shiraz 60 40.00 31 20.66 29 19.33 Zarqan 22 14.67 12 8.00 10 6.67 Maharloo 24 16.00 12 8.00 12 8.00 Sepidan 20 13.33 10 6.67 10 6.67 Marvdasht 24 16.00 13 8.67 11 7.33 Total 150 100.00 78 52.00 72 48.00 Age (year) 20–30 22 14.66 17 11.33 5 3.33 31–40 45 30.00 23 15.33 22 14.67 41–50 43 28.67 21 14.00 22 14.67 51–60 28 18.67 14 9.33 14 9.33 ≥60 12 8.00 3 2.00 9 6.00 Total 150 100.00 78 52.00 72 48.00 Keeping birds 49 32.67 28 18.67 21 14.00 Residence Place Urban 63 42.00 34 22.67 29 19.33 Rural 87 58.00 53 35.33 34 22.67 Table 2. Frequency of positive West Nile virus IgG antibody according to the sex, Fars Province, Southern Iran, 2018 Region Number of Samples Percent from total (%) Positive Cases Gender of positive cases P-value No. Percent from total (%) Male Percent from total (%) Female Percent from total (%) Shiraz 60 40.00 27 18.00 15 36.58 12 29.26 Zarqan 22 14.67 3 2.00 2 4.88 1 2.44 Maharloo 24 16.00 4 2.67 1 2.44 3 7.32 Sepidan 20 13.33 2 1.33 1 2.44 1 2.44 Marvdasht 24 16.00 5 3.33 4 9.76 1 2.44 Total 150 100.00 41 27.33 23 56.10 18 43.90 0.493 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 178 http://jad.tums.ac.ir Published Online: June 30, 2020 Table 3. Frequency of positive West Nile virus IgG antibody according to the age groups, Fars Province, Southern Iran, 2018 Region Age (year) No. Positive Cases Gender of positive cases P-value No. Percent from total (%) Male Percent from total (%) Female Percent from total (%) Shiraz 20–30 12 0 0.00 0 0.00 0 0.00 31–40 23 18 12.00 10 24.39 8 19.51 41–50 13 9 6.00 5 12.19 4 9.76 51–60 8 0 0.00 0 0.00 0 0.00 ≥60 4 0 0.00 0 0.00 0 0.00 Zarqan 20–30 5 0 0.00 0 0.00 0 0.00 31–40 4 0 0.00 0 0.00 0 0.00 41–50 7 2 1.33 2 4.88 0 0.00 51–60 3 1 0.67 0 0.00 1 2.44 ≥60 3 0 0.00 0 0.00 0 0.00 Maharloo 20–30 5 0 0.00 0 0.00 0 0.00 31–40 6 2 1.33 0 0.00 2 4.87 41–50 3 0 0.00 0 0.00 0 0.00 51–60 9 2 1.33 1 2.44 1 2.44 ≥60 1 0 0.00 0 0.00 0 0.00 Sepidan 20–30 4 0 0.00 0 0.00 0 0.00 31–40 3 0 0.00 0 0.00 0 0.00 41–50 7 2 1.33 1 2.44 1 2.44 51–60 4 0 0.00 0 0.00 0 0.00 ≥60 2 0 0.00 0 0.00 0 0.00 Marvdasht 20–30 2 0 0.00 0 0.00 0 0.00 31–40 8 2 1.33 2 4.88 0 0.00 41–50 11 3 2.00 2 4.88 1 2.44 51–60 2 0 0.00 0 0.00 0 0.00 ≥60 1 0 0.00 0 0.00 0 0.00 Total - 150 41 27.32 23 56.10 18 43.90 0.832 Fig. 1. Location of study area and sampling sites in Fars Province, Southern Iran, 2018 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 179 http://jad.tums.ac.ir Published Online: June 30, 2020 Table 4. Frequency of positive West Nile virus IgG antibody based on the history of keeping birds at home, Fars Province, Southern Iran, 2018 Region Number of samples keeping birds Percent from total (%) Positive Cases P-value Total Percent from total (%) Male Percent from total (%) Female Percent from total (%) Shiraz 60 6 4.00 1 2.04 1 7.14 0 0.00 Zarqan 22 8 5.33 2 4.08 1 7.14 1 7.14 Maharloo 24 17 11.33 6 12.24 2 14.29 4 28.57 Sepidan 20 10 6.67 2 4.08 1 7.14 1 7.14 Marvdasht 24 8 5.33 3 6.12 2 14.29 1 7.14 Total 150 49 32.66 14 28.56 7 50.00 7 50.00 0.632 Table 5. Frequency of positive West Nile virus WNV IgG antibody according to living in urban/rural areas, Fars Province, Southern Iran, 2018 Region Number of samples Urban Rural Positive Cases Total Percent from total (%) P-value No. Percent from total (%) No. Percent from total (%) Urban Percent from total (%) Rural Percent from total (%) Shiraz 60 37 24.67 23 15.33 18 28.57 9 10.34 27 18.00 Zarqan 22 8 5.33 14 9.33 1 1.59 2 2.30 3 2.00 Maharloo 24 0 0.00 24 16.00 0 0.00 4 4.60 4 2.67 Sepidan 20 7 4.67 13 8.67 1 1.59 1 1.15 2 1.33 Marvdasht 24 11 7.33 13 8.67 2 3.17 3 3.45 5 3.33 Total 150 63 42.00 87 58.00 22 34.92 19 21.84 41 27.33 0.291 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 180 http://jad.tums.ac.ir Published Online: June 30, 2020 Discussion This is the first record on WNV infection on human in Fars Province, Southern Iran. The study was conducted in five different dis- tricts and we found that the infection rate to WNV was varied based on sex and age of par- ticipants. It seems, males at middle age were more exposing to the mosquito vector bites (Table 2, 3). The statistical analysis showed that none of the demographic factors had a significant relationship with the incidence of antibodies (P> 0.05). We found some evidence indicated that the risk of WNV infection can be age-depend- ent in the study areas. Similarity, a study in Ohio showed that titer of antibody against WNV in the children was 2.5 times higher than adult (33). While another study conduct- ed on immuno- compromised and immuno- compromised patients, age was not a signifi- cant seroconversion factor. Their findings suggest that immune factors affect serocon- version (34). However, the age dependency of WNV infection is controversial. In addition, no significant association was observed between sex and seropositivity of WNV IgG antibody among the voluntaries. Previously, equal infection of WNV was re- ported between both sexes in in United States (35). However, our results may indicate that both sexes had same exposure to the infect- ed bites. As birds are potent reservoirs of WNV, we tried to find out any correlation between keeping birds in the inhabitant houses and WNV infection rate. Noticeably, 28.56% of residents which kept birds were positive to WNV IgG antibody. Of course, these positives may be related to exposure to the virus in pre- vious years. Generally, birds are attractive blood source for Culex spp (36, 37), there- fore, keeping birds at home can cause dis- traction of mosquitoes from human to birds and thus help reduce disease transmission to human. We also found higher infection rate in urban areas comparing to rural. Cycle of WNV in nature always occur be- tween birds and mosquito vectors. Therefore, density of birds around inhabitants rise trans- mission of the disease among communities′ members in endemic area, while only 28.56 % of participants who kept birds at home were positive and we could not find any as- sociation between WNV IgG positive rate and those who kept birds at home. It likely, presence of birds around human can be good alternative blood source for the mosquito vec- tors. Therefore, the relationship between rate of WNV infection and keeping birds is so controversial and it is depended to situation of virus transmission in area. West Nile Virus transmission may be var- ied based on rural and urban areas (38-40). It is stated that the rate of WNV infection was higher in rural areas comparing with urban ar- eas in Bucharest and Culex pipiens was dom- inant mosquito species (41). While we also found higher positive antibody among urban residents where Cx. pipiens was relatively dominant (unpublished). In addition, poor drainage, catch basins, sewage, and manmade containers around houses of urban residents provide good larval development sites for Cx. pipiens. Moreover, poor of alternative blood source for vectors may convey the mosquito to human inhabitants in urban area. As there is no complete cure or effective vaccine for the virus, therefore monitoring and surveillance studies regarding WNV prev- alence is an important tool for health care spe- cialists to have a future regarding this life- threatening arbovirus in order to choose the best protective plans. As well, climate variation due to world- wide warming in recent years may increase mosquito activity period that can lead to es- calating virus prevalence. Because of climate differences in Iran, the dispersal and richness of mosquito differs in different provinces of J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 181 http://jad.tums.ac.ir Published Online: June 30, 2020 Iran. Therefore, in provinces where the weath- er is warmer, the life span of the mosquitoes is also increased, resulting in a higher chance of transmission. Seroepidemiological studies are necessary to define the prevalence of WNV in other parts of Iran for better decision making in the future. Conclusions These results suggest circulation and ex- posure of the human population to WNV in south of Iran. The knowledge generated from this study will further contribute to our un- derstanding of the ecology and epidemiol- ogy of WNV fever in Iran and will assist in the provision of public health measures to reduce the risk of exposure to the virus. It is notable that the high volume of tourist traf- fic in Fars Province and other economic sig- nificance of the province, awareness of the cycle of this disease is necessary and the in- formation from this project will be used to plan the control of transmission and outbreak in Fars Province and other neighboring prov- inces. Previous studies have shown that hors- es have antibodies in the study area. The study also found that people living in the area were also in contact with the virus. Of course, the authors of this article have also researched on the probable vectors of WNV in this study area which will be published in the future. Certainly, future studies on the birds and their infection with the West Nile Virus can help to clarify the disease situation in this area. Acknowledgements The authors would like to thank School of Public Health, Tehran University of Med- ical Sciences, Tehran, Iran, for their assis- tance in carrying out this research (Project No.37365). This study was supported by Na- tional Institute for Medical Research Devel- opment (Grant No.940947). The authors de clare that there is no conflict of interests. References 1. Meshkat Z, Chinikar S, Shakeri M, Ma- navifar L, Moradi M, Mirshahabi H, Jalali T, Khakifirouz S, Shahhosseini N (2015) Prevalence of West Nile vi- rus in Mashhad, Iran: A population- based study. Asian Pac J Trop Med. 8 (3): 203–205. 2. Cao L, Fu S, Lu Z, Tang C, Gao X, Li X, Lei W, He Y, Li M, Cao Y, Wang H, Liang G (2019) Detection of West Nile virus infection in viral encephalitis cas- es, China. Vector Borne Zoonotic Dis. 19(1): 45–50. 3. Martínez-de la Puente J, Ferraguti M, Ruiz S, Roiz D, Llorente F, Pérez-Ramírez E, Jiménez-Clavero MA, Soriguer R, Figuerola J (2018) Mosquito commu- nity influences West Nile Virus sero- prevalence in wild birds: implications for the risk of spillover into human pop- ulations. Sci Rep. 8(1): 2599. 4. Fereidouni SR, Ziegler U, Linke S, Nie- drig M, Modirrousta H, Hoffmann B, Groschup MH (2011) West Nile virus monitoring in migrating and resident water birds in Iran: Are common coots the main reservoirs of the virus in wet- lands? Vector Borne Zoonotic Dis. 11 (10): 1377–1381. 5. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E (2012) West Nile virus: biology, transmission, and human infec- tion. Clin Microbiol Rev. 25(4): 635– 648. 6. Chinikar S, Shah-Hosseini N, Mostafavi E, Moradi M, Khakifirouz S, Jalali T, Goya MM, Shirzadi MR, Zainali M, Fooks AR (2013) Seroprevalence of West Nile virus in Iran. Vector Borne Zoonotic Dis. 13: 586–589. 7. Eybpoosh S, Fazlalipour M, Baniasadi V, Pouriayevali MH, Sadeghi F, Ahmadi- https://www.ncbi.nlm.nih.gov/pubmed/?term=Meshkat%20Z%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Chinikar%20S%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shakeri%20M%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Manavifar%20L%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Manavifar%20L%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Moradi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mirshahabi%20H%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Jalali%20T%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Khakifirouz%20S%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shahhosseini%20N%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shahhosseini%20N%5BAuthor%5D&cauthor=true&cauthor_uid=25902161 https://www.ncbi.nlm.nih.gov/pubmed/?term=Cao%20L%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fu%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Lu%20Z%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Tang%20C%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Gao%20X%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Li%20X%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Lei%20W%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=He%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Li%20M%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Cao%20Y%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Wang%20H%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=Liang%20G%5BAuthor%5D&cauthor=true&cauthor_uid=29985780 https://www.ncbi.nlm.nih.gov/pubmed/29985780 https://www.ncbi.nlm.nih.gov/pubmed/?term=West+Nile+virus+seroprevalence+in+wild+birds%2C+Josu%C3%A9+Mart%C3%ADnez-de+la+Puente https://www.ncbi.nlm.nih.gov/pubmed/?term=Fereidouni%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ziegler%20U%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Linke%20S%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Niedrig%20M%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Niedrig%20M%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Modirrousta%20H%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Hoffmann%20B%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Groschup%20MH%5BAuthor%5D&cauthor=true&cauthor_uid=21923253 https://www.ncbi.nlm.nih.gov/pubmed/?term=Chinikar%20S%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shah-Hosseini%20N%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mostafavi%20E%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mostafavi%20E%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Moradi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Khakifirouz%20S%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Jalali%20T%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Goya%20MM%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shirzadi%20MR%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Zainali%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fooks%20AR%5BAuthor%5D&cauthor=true&cauthor_uid=23697768 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 182 http://jad.tums.ac.ir Published Online: June 30, 2020 Vasmehjani A, Karbalaie Niya MH, Hewson R, Salehi-Vaziri M (2019) Ep- idemiology of West Nile virus in the Eastern Mediterranean region: A sys- tematic review. PLoS Negl Trop Dis. 13(1): e0007081. 8. Busquets N, Laranjo-González M, Soler M, Nicolás O, Rivas R, Talavera S (2019) Detection of West Nile virus lineage 2 in North-Eastern Spain (Cat- alonia). Trans Emerg Dis. 66(2): 617– 621. 9. Pradier S, Lecollinet S, Leblond A (2012) West Nile virus epidemiology and fac- tors triggering change in its distribu- tion in Europe. Rev Sci Tech off Int Epiz. 31(3): 829–844. 10. Anukumara B, Sapkal GN, Tandaleb BV, Balasubramanian R, Gangaleb D (2014) West Nile encephalitis outbreak in Ker- ala, India, 2011. J Clin Virol. 61(1): 152– 155. 11. Ozan E, Albayrak H, Gumusova S, Bo- lukbas CS, Kurt M, Pekmezci GZ, Beyhan YE, Kadi H, Kaya S, Aydin I, Yazici Z (2019) A study on the identi- fication of five arboviruses from hema- tophagous mosquitoes and midges cap- tured in some parts of northern Turkey. J Arthropod Borne Dis. 13(2): 224–233. 12. Brugman VA, Hernández-Triana LM, Medlock JM, Fooks AR, Carpenter S, Johnson N (2018) The role of Culex pipiens L. (Diptera: Culicidae) in virus transmission in Europe. Int J Environ Res Public Health. 15(2): 389–395. 13. Brugman VA, Hernández-Triana LM, England ME, Medlock JM, Mertens PPC, Logan JG, Wilson AJ, Fooks AR, Johnson N, Carpenter S (2017) Blood- feeding patterns of native mosquitoes and insights into their potential role as pathogen vectors in the Thames estu- ary region of the United Kingdom. Par- asite Vector. 10: 163–169. 14. Beasley DW, Barrett AD, Tesh RB (2013) Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done? Antiviral Res. 99: 1–5. 15. Chaintoutisa C, Gewehrb S, Mourelatosb S, Dovasa CI (2016) Serological moni- toring of backyard chickens in central Macedonia-Greece can detect low trans- mission of West Nile virus in the ab- sence of human neuroinvasive disease cases. Acta Trop. 163: 26–31. 16. Hamer GL, Kitron UD, Brawn JD, Loss SR, Ruiz MO, Goldberg TL, Walker ED (2008) Culex pipiens (Diptera: Cu- licidae): a bridge vector of West Nile virus to humans. J Med Entomol. 45 (1): 125–128. 17. Papa A (2013) West Nile virus infec- tions in humans-focus on Greece. J Clin Virol. 58: 351–353. 18. Benjelloun A, El Harrak M, Belkadi B (2016) West Nile disease epidemiolo- gy in North-West Africa: bibliograph- ical review. Transbound Emerg Dis. 63 (6): 153–159. 19. Del Giudice P, Schuffenecker I, Vanden- bos F, Counillon E, Zeller H (2004) Human West Nile virus, France. Emerg Infect Dis. 10(10): 1885–1886. 20. Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C (2000) Evaluation of immunoglobulin M (IgM) and IgG en- zyme immunoassays in serologic diag- nosis of West Nile virus infection. J Clin Microbiol. 38(6): 2232–2239. 21. Prince HE, Tobler LH, Lape-Nixon M, Foster GA, Stramer SL, Busch MP (2005) Development and persistence of West Nile virus-specific Immunoglobu- lin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol. 43: 4316–4320. 22. Komar N, Panella N, YoungG, Basile A (2015) Methods for detection of West Nile virus antibodies In mosquito blood meals. J Am Mosq Control Assoc. 31 https://www.ncbi.nlm.nih.gov/pubmed/30695031 https://www.ncbi.nlm.nih.gov/pubmed/?term=Busquets%20N%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Laranjo-Gonz%C3%A1lez%20M%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Soler%20M%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Soler%20M%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Nicol%C3%A1s%20O%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Rivas%20R%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/?term=Talavera%20S%5BAuthor%5D&cauthor=true&cauthor_uid=30506625 https://www.ncbi.nlm.nih.gov/pubmed/30506625 https://www.sciencedirect.com/science/article/abs/pii/S1386653214002170?via%3Dihub#! https://www.sciencedirect.com/science/article/abs/pii/S1386653214002170?via%3Dihub#! https://www.sciencedirect.com/science/article/abs/pii/S1386653214002170?via%3Dihub#! https://www.sciencedirect.com/science/article/abs/pii/S1386653214002170?via%3Dihub#! https://www.sciencedirect.com/science/article/abs/pii/S1386653214002170?via%3Dihub#! https://www.sciencedirect.com/science/journal/13866532 https://www.sciencedirect.com/science/journal/13866532/61/1 https://www.ncbi.nlm.nih.gov/pubmed/?term=Brugman%20VA%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://www.ncbi.nlm.nih.gov/pubmed/?term=Hern%C3%A1ndez-Triana%20LM%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://www.ncbi.nlm.nih.gov/pubmed/?term=Medlock%20JM%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fooks%20AR%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://www.ncbi.nlm.nih.gov/pubmed/?term=Carpenter%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://www.ncbi.nlm.nih.gov/pubmed/?term=Johnson%20N%5BAuthor%5D&cauthor=true&cauthor_uid=29473903 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-1 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-2 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-3 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-4 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-5 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-6 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-7 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-8 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-9 https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2098-4#auth-10 https://www.ncbi.nlm.nih.gov/pubmed/?term=Hamer%20GL%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Kitron%20UD%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Brawn%20JD%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Loss%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Loss%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ruiz%20MO%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Goldberg%20TL%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Walker%20ED%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Walker%20ED%5BAuthor%5D&cauthor=true&cauthor_uid=18283952 https://www.ncbi.nlm.nih.gov/pubmed/18283952 https://www.ncbi.nlm.nih.gov/pubmed/?term=Benjelloun%20A%5BAuthor%5D&cauthor=true&cauthor_uid=25753775 https://www.ncbi.nlm.nih.gov/pubmed/?term=El%20Harrak%20M%5BAuthor%5D&cauthor=true&cauthor_uid=25753775 https://www.ncbi.nlm.nih.gov/pubmed/?term=Belkadi%20B%5BAuthor%5D&cauthor=true&cauthor_uid=25753775 https://www.ncbi.nlm.nih.gov/pubmed/25753775 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 183 http://jad.tums.ac.ir Published Online: June 30, 2020 (1): 1–6. 23. Chinikar S, Javadi A, Ataei B, Shakeri H, Moradi M, Mostafavi E, Ghiasi SM (2012) Detection of West Nile virus ge- nome and specific antibodies in Iranian encephalitis patients. Epidemiol Infect. 140: 1525–1529. 24. Papa A, Anastasiadou A, Delianidou M (2015) West Nile virus IgM and IgG antibodies three years post-infection. Hippokratia. 19(1): 34–36. 25. Ahmadnejad F, Otarod V, Fallah MH, Lowenski S, Sedighi-Moghaddam R, Zavareh A, Durand B, Lecollinet S, Sabatier P (2011) Spread of West Nile virus in Iran: A cross-sectional sero- survey in equines, 2008–2009. Epide- miol Infect. 139(10): 1587–1593. 26. Saidi S, Tesh R, Javadian E, Nadim A (1976) The prevalence of human infec- tion with West Nile virus in Iran. Iran J Public Health. 5: 8–13. 27. Naficy K, Saidi S (1970) Serological sur- vey on viral antibodies in Iran. Trop Ge- ogr Med. 22(2): 183–188. 28. Sharifi Z, Shooshtari M, Talebian A (2010) A study of West Nile virus infection in Iranian blood donors. Arch Iran Med. 13(1): 1–4. 29. Talebian A (2010) A study of West Nile virus infection in Iranian blood donors. Arch Iran Med. 13(1): 1–4. 30. Aghaie A, Aaskov J, Chinikar S, Niedrig M, Banazadeh S, Mohammadpour HK (2016) Frequency of West Nile virus infection in Iranian blood donors. Indi- an J Hematol Blood Transfus. 32(3): 343–346. 31. Enghiad M (2015) Serologic survey of West Nile Virus in horses from Fars Province. [PhD dissertation]. Veterinary School, Shiraz University, Iran. 32. Malan AK, Martins TB, Hill HR, Litwin CM (2004) Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous valida- tion. J Clin Microbiol. 42(2): 727–733. 33. Mandalakas A, Kippes C, Sedransk J, Kile JR (2005) West Nile virus epi- demic, Northeast Ohio, 2002. Emerg In- fect Dis. 11(11): 1774–1777. 34. Huhn GD, Sejvar JJ, Montgomery SP, Dworkin MS (2003) West Nile virus in the United States: An update on an emerging infectious disease. Am Fam Physician. 68(4): 653–660. 35. Ruggieri A, Anticoli S, D’Ambrosio A, Giordani L, Viora M (2016) The influ- ence of sex and gender on immunity, infection and vaccination. Ann Ist Su- per Sanità. 52(2): 198–204. 36. Reed KD, Meece JK, Henkel JS, Shukla SK (2003) Birds, migration and emerg- ing zoonosis: West Nile virus, Lyme disease, Influenza A and Enteropatho- gens. Clin Med Res.1(1): 5–12. 37. Bagheri M, Terenius O, Oshaghi MA, Motazakker M, Asgari S, Dabiri F, Vatandoost H, Mohammadi Bavani M, Chavshin AR (2015) West Nile virus in mosquitoes of Iranian wetlands. Vec- tor Borne Zoonotic Dis. 15(12): 750–754. 38. Keyel AC, Timm OE, P. Backenson B, Prussing C, Quinones S, McDonough KA, Vuille M, Conn JE, Armstrong PM, Andreadis TA, Kramer LD (2019) Sea- sonal temperatures and hydrological con- ditions improve the prediction of West Nile virus infection rates in Culex mos- quitoes and human case counts in New York and Connecticut. PLoS One. 14 (6): e0217854. 39. Ahmadnejad F, Otarod V, Fathnia A, Ahmadabadi A, Fallah MH, Zavareh A, Miandehi N, Durand B, Sabatier P (2016) Impact of climate and environ- mental factors on West Nile virus cir- culation in Iran. J Arthropod-Borne Dis. 10(3): 315–327. 40. Hartley DM, Barker CM, Le Menach A, Niu T, Gaff HD, Reisen WK (2012) https://www.ncbi.nlm.nih.gov/pubmed/?term=Chinikar%20S%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Javadi%20A%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ataei%20B%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shakeri%20H%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shakeri%20H%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Moradi%20M%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mostafavi%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ghiasi%20SM%5BAuthor%5D&cauthor=true&cauthor_uid=22008154 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ahmadnejad%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Otarod%20V%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fallah%20MH%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Lowenski%20S%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Sedighi-Moghaddam%20R%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Zavareh%20A%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Durand%20B%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Lecollinet%20S%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Sabatier%20P%5BAuthor%5D&cauthor=true&cauthor_uid=21396143 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ahmadnejad+F%2C2011 https://www.ncbi.nlm.nih.gov/pubmed/?term=Ahmadnejad+F%2C2011 https://www.ncbi.nlm.nih.gov/pubmed/?term=Aghaie%20A%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Aaskov%20J%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Chinikar%20S%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Niedrig%20M%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Niedrig%20M%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Banazadeh%20S%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mohammadpour%20HK%5BAuthor%5D&cauthor=true&cauthor_uid=27429528 https://www.ncbi.nlm.nih.gov/pubmed/27429528 https://www.ncbi.nlm.nih.gov/pubmed/27429528 https://www.researchgate.net/profile/Anna_Mandalakas https://www.researchgate.net/profile/Christopher_Kippes2 https://www.researchgate.net/profile/Joseph_Sedransk https://www.researchgate.net/scientific-contributions/30454634_Jeffrey_R_Kile https://www.researchgate.net/scientific-contributions/30454634_Jeffrey_R_Kile https://www.researchgate.net/journal/1080-6040_Emerging_infectious_diseases https://www.researchgate.net/journal/1080-6040_Emerging_infectious_diseases https://www.ncbi.nlm.nih.gov/pubmed/?term=Reed%20KD%5BAuthor%5D&cauthor=true&cauthor_uid=15931279 https://www.ncbi.nlm.nih.gov/pubmed/?term=Meece%20JK%5BAuthor%5D&cauthor=true&cauthor_uid=15931279 https://www.ncbi.nlm.nih.gov/pubmed/?term=Henkel%20JS%5BAuthor%5D&cauthor=true&cauthor_uid=15931279 https://www.ncbi.nlm.nih.gov/pubmed/?term=Shukla%20SK%5BAuthor%5D&cauthor=true&cauthor_uid=15931279 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1069015/ https://www.ncbi.nlm.nih.gov/pubmed/31158250 J Arthropod-Borne Dis, June 2020, 14(2): 173–184 M Amin et al.: Seroprevalence Study on … 184 http://jad.tums.ac.ir Published Online: June 30, 2020 Effects of temperature on emergence and seasonality of West Nile virus in California. Am J Trop Med Hyg. 86(5): 884–894. 41. Mavridis K, Fotakis EA, Kioulos I, Mpel-- lou S, Konstantas S, Varela E, Gewehr S, Diamantopoulos V, Vontas J (2018) Detection of West Nile virus-lineage 2 in Culex pipiens mosquitoes, associated with disease outbreak in Greece, 2017. Acta Trop. 182: 64–68. https://www.ncbi.nlm.nih.gov/pubmed/?term=Mavridis%20K%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Fotakis%20EA%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Kioulos%20I%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mpellou%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Mpellou%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Konstantas%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Varela%20E%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Gewehr%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Gewehr%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Diamantopoulos%20V%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/?term=Vontas%20J%5BAuthor%5D&cauthor=true&cauthor_uid=29474832 https://www.ncbi.nlm.nih.gov/pubmed/29474832